Skip to main content
PMC home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1996 Aug;59(2):301–307.

Cost comparison of molecular versus conventional screening of relatives at risk for retinoblastoma.

H Z Noorani 1, H N Khan 1, B L Gallie 1, A S Detsky 1
PMCID: PMC1914748  PMID: 8755916

Abstract

To compare costs of molecular and conventional screening of retinoblastoma relatives, we evaluated the direct health care costs. With variables set at the most likely values (baseline), the expected cost (in 1994 Canadian dollars) of conventional screening was $31,430 for a prototype family consisting of seven at-risk relatives (three clinic exams and eight examinations under anaesthetic over the first 3 years of life for each relative). For the molecular strategy that involves looking for the RB1 gene mutation in the proband, testing the relatives for that mutation, and clinical follow-up similar to conventional strategy for relatives with mutation, the expected cost was $8,674, using baseline variables. Sensitivity analysis over the range of values for each variable revealed a significant saving of health care dollars by the molecular route, indicating the benefit of redirecting economic resources to molecular diagnosis in retinoblastoma.

Full text

PDF
301

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barr F. G., Chatten J., D'Cruz C. M., Wilson A. E., Nauta L. E., Nycum L. M., Biegel J. A., Womer R. B. Molecular assays for chromosomal translocations in the diagnosis of pediatric soft tissue sarcomas. JAMA. 1995 Feb 15;273(7):553–557. [PubMed] [Google Scholar]
  2. Blanquet V., Turleau C., Gross-Morand M. S., Sénamaud-Beaufort C., Doz F., Besmond C. Spectrum of germline mutations in the RB1 gene: a study of 232 patients with hereditary and non hereditary retinoblastoma. Hum Mol Genet. 1995 Mar;4(3):383–388. doi: 10.1093/hmg/4.3.383. [DOI] [PubMed] [Google Scholar]
  3. Bonaïti-Pellié C., Briard-Guillemot M. L. Segregation analysis in hereditary retinoblastoma. Hum Genet. 1981;57(4):411–419. doi: 10.1007/BF00281695. [DOI] [PubMed] [Google Scholar]
  4. Cavenee W. K., Dryja T. P., Phillips R. A., Benedict W. F., Godbout R., Gallie B. L., Murphree A. L., Strong L. C., White R. L. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. 1983 Oct 27-Nov 2Nature. 305(5937):779–784. doi: 10.1038/305779a0. [DOI] [PubMed] [Google Scholar]
  5. Comings D. E. A general theory of carcinogenesis. Proc Natl Acad Sci U S A. 1973 Dec;70(12):3324–3328. doi: 10.1073/pnas.70.12.3324. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Draper G. J., Sanders B. M., Brownbill P. A., Hawkins M. M. Patterns of risk of hereditary retinoblastoma and applications to genetic counselling. Br J Cancer. 1992 Jul;66(1):211–219. doi: 10.1038/bjc.1992.244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dunn J. M., Phillips R. A., Zhu X., Becker A., Gallie B. L. Mutations in the RB1 gene and their effects on transcription. Mol Cell Biol. 1989 Nov;9(11):4596–4604. doi: 10.1128/mcb.9.11.4596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Eng C., Li F. P., Abramson D. H., Ellsworth R. M., Wong F. L., Goldman M. B., Seddon J., Tarbell N., Boice J. D., Jr Mortality from second tumors among long-term survivors of retinoblastoma. J Natl Cancer Inst. 1993 Jul 21;85(14):1121–1128. doi: 10.1093/jnci/85.14.1121. [DOI] [PubMed] [Google Scholar]
  9. Friend S. H., Bernards R., Rogelj S., Weinberg R. A., Rapaport J. M., Albert D. M., Dryja T. P. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature. 1986 Oct 16;323(6089):643–646. doi: 10.1038/323643a0. [DOI] [PubMed] [Google Scholar]
  10. Gallie B. L., Dunn J. M., Chan H. S., Hamel P. A., Phillips R. A. The genetics of retinoblastoma. Relevance to the patient. Pediatr Clin North Am. 1991 Apr;38(2):299–315. doi: 10.1016/s0031-3955(16)38079-8. [DOI] [PubMed] [Google Scholar]
  11. Gill R. M., Hamel P. A., Zhe J., Zacksenhaus E., Gallie B. L., Phillips R. A. Characterization of the human RB1 promoter and of elements involved in transcriptional regulation. Cell Growth Differ. 1994 May;5(5):467–474. [PubMed] [Google Scholar]
  12. Kassirer J. P., Moskowitz A. J., Lau J., Pauker S. G. Decision analysis: a progress report. Ann Intern Med. 1987 Feb;106(2):275–291. doi: 10.7326/0003-4819-106-2-275. [DOI] [PubMed] [Google Scholar]
  13. Lohmann D. R., Brandt B., Höpping W., Passarge E., Horsthemke B. Distinct RB1 gene mutations with low penetrance in hereditary retinoblastoma. Hum Genet. 1994 Oct;94(4):349–354. doi: 10.1007/BF00201591. [DOI] [PubMed] [Google Scholar]
  14. Lohmann D., Horsthemke B., Gillessen-Kaesbach G., Stefani F. H., Höfler H. Detection of small RB1 gene deletions in retinoblastoma by multiplex PCR and high-resolution gel electrophoresis. Hum Genet. 1992 Apr;89(1):49–53. doi: 10.1007/BF00207041. [DOI] [PubMed] [Google Scholar]
  15. Matsunaga E. Hereditary retinoblastoma: penetrance, expressivity and age of onset. Hum Genet. 1976 Jul 7;33(1):1–15. doi: 10.1007/BF00447281. [DOI] [PubMed] [Google Scholar]
  16. McGee T. L., Yandell D. W., Dryja T. P. Structure and partial genomic sequence of the human retinoblastoma susceptibility gene. Gene. 1989 Aug 1;80(1):119–128. doi: 10.1016/0378-1119(89)90256-4. [DOI] [PubMed] [Google Scholar]
  17. Musarella M. A., Gallie B. L. A simplified scheme for genetic counseling in retinoblastoma. J Pediatr Ophthalmol Strabismus. 1987 May-Jun;24(3):124–125. doi: 10.3928/0191-3913-19870501-06. [DOI] [PubMed] [Google Scholar]
  18. Pauker S. G., Kassirer J. P. The threshold approach to clinical decision making. N Engl J Med. 1980 May 15;302(20):1109–1117. doi: 10.1056/NEJM198005153022003. [DOI] [PubMed] [Google Scholar]
  19. Tamboli A., Podgor M. J., Horm J. W. The incidence of retinoblastoma in the United States: 1974 through 1985. Arch Ophthalmol. 1990 Jan;108(1):128–132. doi: 10.1001/archopht.1990.01070030134045. [DOI] [PubMed] [Google Scholar]
  20. Torrance G. W. Utility approach to measuring health-related quality of life. J Chronic Dis. 1987;40(6):593–603. doi: 10.1016/0021-9681(87)90019-1. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES